Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > 2021 Insider Buying

<< Previous

Bullboard Posts

Next >>

Comment by canadapieton Oct 25, 2021 3:33pm

129 Views

Post# 34046675

RE:RE:2021 Insider Buying

BIG PHARMA = NOT INTERESTED!!!!!

Only my idea

The Big Ones are very much interested in ONCOLOGY and NASH/NAFLD.
Every B P is looking for deals/BO to fill their pipeline/income. There were allready many small,
medium and big deals done in those markets in the past.
TH is not a young company, so every BP knows their history.
In short, none of them are looking for Tesamorelin or Trogarzo to fill a "gap" in their pipeline and whats worse, none of them have any interest in their Nash or Oncology programs!!!
But the "most" worst of all is that BOD is saying that TH shareprice is RIDICULOUSY LOW and then forget to buy...........!! Hilarious!!

Goor luck all